Hub : Traits :

Body Mass Index (BMI) (2010)

310 significantly associated models · 46 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 71163715 73435171 1 1 1.3e-13 1.2e-14 1.8e-03 84 NEGR1
2 2 24348096 25837917 1 1 1.3e-07 1.8e-07 3.6e-01 97 ADCY3
3 3 140514022 142017527 1 1 3.0e-07 1.1e-06 6.3e-02 85 RASA2
4 3 185520342 186072370 1 1 2.2e-12 1.3e-12 2.2e-02 90 ETV5
5 11 46570859 48485877 11 1 2.5e-11 4.8e-11 1.0e+00 100 C1QTNF4
6 12 49569311 50991370 1 1 2.2e-08 4.0e-11 1.3e-04 67 FAIM2
7 13 27315078 28717392 1 1 1.3e-07 3.0e-07 5.6e-02 86 MTIF3
8 15 67138238 68789191 1 1 2.6e-11 1.2e-10 1.3e-01 94 MAP2K5
9 16 19022448 20596558 5 1 9.8e-11 4.6e-11 1.0e+00 100 GPRC5B
10 16 27655848 29595483 19 1 3.1e-13 1.7e-10 2.4e-01 97 EIF3CL
11 16 52828325 54846383 2 2 1.0e-17 3.1e-62 7.9e-37 42 AKTIP FTO
12 18 57349900 58729694 1 1 2.6e-07 2.1e-22 1.1e-16 28 MC4R
13 19 34044119 34553925 1 1 2.3e-07 2.4e-09 1.0e+00 100 KCTD15

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Depressed Affect (Nagel 2018) 2.50 1 1 2.2 0.00 1.0e+00 C1QTNF4
Intelligence (Savage-Jansen 2018) 6.79 3 2 4.4 0.00 1.0e+00 C1QTNF4 EIF3CL NEGR1
Neuroticism (Nagel 2018) 3.03 2 1 2.2 0.00 1.0e+00 C1QTNF4 MC4R
Worry (Nagel 2018) 3.44 2 2 4.4 0.00 1.0e+00 C1QTNF4 MC4R
Crohns Disease (2017) 3.84 2 2 4.4 0.00 1.0e+00 ADCY3 EIF3CL
Irritable Bowel Disease (IBD) 3.55 2 2 4.4 0.00 1.0e+00 ADCY3 EIF3CL
Ulcerative Colitis (UC) 1.70 1 0 0.0 0.00 1.0e+00 EIF3CL
Major Depression (MDD) 3.63 1 1 2.2 0.00 1.0e+00 NEGR1
Reaction Time 1.01 1 0 0.0 0.00 1.0e+00 ADCY3
Verbal and Numeric Reasoning (VNR) 5.88 4 2 4.4 -0.05 9.5e-01 ADCY3 C1QTNF4 EIF3CL NEGR1
Breast Cancer 4.09 3 1 2.2 0.00 1.0e+00 ADCY3 AKTIP FTO
Crohns Disease (2012) 3.93 2 1 2.2 0.00 1.0e+00 ADCY3 EIF3CL
HDL Cholesterol 3.73 1 0 0.0 0.00 1.0e+00 C1QTNF4
Neuroticism (2016) 2.41 1 0 0.0 0.00 1.0e+00 C1QTNF4
Type 2 Diabetes (T2D) (2012) 3.56 1 0 0.0 0.00 1.0e+00 MC4R
Blood Eosinophil Count 0.74 1 0 0.0 0.00 1.0e+00 ADCY3
Blood Platelet Count 1.31 2 2 4.4 0.00 1.0e+00 C1QTNF4 GPRC5B
Blood Red Count 1.31 3 2 4.4 0.00 1.0e+00 EIF3CL ETV5 RASA2
Blood White Count 1.68 3 1 2.2 0.00 1.0e+00 ADCY3 C1QTNF4 MAP2K5
Heel T-Score 0.93 3 2 4.4 0.00 1.0e+00 FAIM2 GPRC5B NEGR1
BMI 28.35 14 14 31.1 0.96 3.7e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Height 3.04 5 4 8.9 -0.38 5.3e-01 ADCY3 C1QTNF4 GPRC5B MC4R MTIF3
Waist Hip Ratio (WHR) 0.85 1 0 0.0 0.00 1.0e+00 FTO
Systolic Blood Pressure 2.70 2 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4
Smoking Status 1.82 1 0 0.0 0.00 1.0e+00 ADCY3
Allergy or Eczema 1.78 2 1 2.2 0.00 1.0e+00 EIF3CL NEGR1
Cardiovascular Disease 2.33 2 1 2.2 0.00 1.0e+00 FTO NEGR1
Type 2 Diabetes (T2D) (2018) 4.10 2 0 0.0 0.00 1.0e+00 AKTIP C1QTNF4
Lung FEV1/FVC ratio 1.64 2 2 4.4 0.00 1.0e+00 ADCY3 NEGR1
Lung FVC 1.33 2 1 2.2 0.00 1.0e+00 EIF3CL MAP2K5
Neuroticism 2.98 3 1 2.2 0.00 1.0e+00 C1QTNF4 MAP2K5 MC4R
Chronotype (morning person) 3.24 4 1 2.2 0.69 3.1e-01 ADCY3 AKTIP C1QTNF4 FTO
Hair Pigment 0.15 1 0 0.0 0.00 1.0e+00 ADCY3
Tanning 0.44 2 1 2.2 0.00 1.0e+00 ADCY3 C1QTNF4
Hand grip strength (left) 4.39 3 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4 GPRC5B
Number of treatments/medications taken 1.59 1 0 0.0 0.00 1.0e+00 NEGR1
Frequency of depressed mood in last 2 weeks 1.85 1 0 0.0 0.00 1.0e+00 C1QTNF4
Medication: Metformin 4.08 1 0 0.0 0.00 1.0e+00 C1QTNF4
Pack years adult smoking proportion 1.64 1 0 0.0 0.00 1.0e+00 EIF3CL
Impedance of leg (right) 13.91 13 10 22.2 -0.94 1.4e-06 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1 RASA2
Leg fat-free mass (left) 13.41 11 11 24.4 0.95 5.2e-06 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Trunk fat percentage 14.98 11 9 20.0 0.93 2.6e-05 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R MTIF3 NEGR1
Hand grip strength (right) 3.59 4 2 4.4 -0.74 2.6e-01 ADCY3 C1QTNF4 EIF3CL GPRC5B
Townsend deprivation index at recruitment 2.77 1 0 0.0 0.00 1.0e+00 MAP2K5
Current tobacco smoking 2.28 1 0 0.0 0.00 1.0e+00 C1QTNF4
Taking other prescription medications 1.64 1 0 0.0 0.00 1.0e+00 NEGR1
Age when periods started (menarche) 9.22 9 5 11.1 -0.99 9.6e-07 ADCY3 AKTIP C1QTNF4 ETV5 FAIM2 FTO GPRC5B MAP2K5 NEGR1
High blood pressure 1.95 1 0 0.0 0.00 1.0e+00 NEGR1
Hayfever, allergic rhinitis or eczema 1.36 1 0 0.0 0.00 1.0e+00 NEGR1
Multivitamins +/- minerals 2.39 1 0 0.0 0.00 1.0e+00 NEGR1
Sitting height 3.68 3 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4 MTIF3
Body mass index (BMI) 22.95 14 11 24.4 0.96 4.7e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Impedance of leg (left) 13.79 13 9 20.0 -0.93 3.0e-06 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg predicted mass (left) 13.39 11 11 24.4 0.95 5.3e-06 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Trunk fat mass 16.52 13 11 24.4 0.95 5.2e-07 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Waist circumference 18.78 13 11 24.4 0.97 9.6e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Past tobacco smoking 3.08 2 0 0.0 0.00 1.0e+00 ADCY3 MAP2K5
Alcohol usually taken with meals 2.91 2 0 0.0 0.00 1.0e+00 EIF3CL NEGR1
Forced vital capacity (FVC) 2.59 2 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4
Qualifications: None of the above 3.04 2 2 4.4 0.00 1.0e+00 EIF3CL NEGR1
Allergy 0.98 1 0 0.0 0.00 1.0e+00 NEGR1
Fluid intelligence score 5.01 3 2 4.4 0.00 1.0e+00 C1QTNF4 EIF3CL NEGR1
Neuroticism score 2.91 2 1 2.2 0.00 1.0e+00 C1QTNF4 MC4R
Weight 16.77 14 13 28.9 0.95 1.1e-07 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Impedance of arm (right) 8.25 9 7 15.6 -0.96 3.4e-05 AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1
Arm fat percentage (right) 21.14 13 11 24.4 0.94 2.4e-06 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Trunk fat-free mass 8.28 11 8 17.8 0.82 2.2e-03 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MC4R MTIF3 NEGR1
Hip circumference 17.78 14 12 26.7 0.95 1.3e-07 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Alcohol intake versus 10 years previously 2.02 1 0 0.0 0.00 1.0e+00 NEGR1
Worrier / anxious feelings 2.48 1 0 0.0 0.00 1.0e+00 MC4R
Forced expiratory volume in 1-second (FEV1) 1.90 2 1 2.2 0.00 1.0e+00 ADCY3 C1QTNF4
Qualifications: A levels/AS levels or equivalent 1.84 2 1 2.2 0.00 1.0e+00 EIF3CL NEGR1
Serious illness, injury or assault of a close relative in last 2 years 1.94 1 0 0.0 0.00 1.0e+00 EIF3CL
Forced expiratory volume in 1-second (FEV1), Best measure 1.71 2 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4
Impedance of arm (left) 8.47 9 6 13.3 -0.95 6.9e-05 AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1
Arm fat mass (right) 21.32 14 12 26.7 0.96 6.1e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Trunk predicted mass 8.31 11 7 15.6 0.82 2.1e-03 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MC4R MTIF3 NEGR1
Standing height 3.34 4 3 6.7 -0.17 8.3e-01 ADCY3 C1QTNF4 EIF3CL MC4R
Seen doctor (GP) for nerves, anxiety, tension or depression 4.77 2 1 2.2 0.00 1.0e+00 MAP2K5 NEGR1
Birth weight of first child 1.57 1 0 0.0 0.00 1.0e+00 EIF3CL
Peak expiratory flow (PEF) 1.31 2 0 0.0 0.00 1.0e+00 ADCY3 C1QTNF4
Medication for cholesterol, blood pressure or diabetes 2.61 1 0 0.0 0.00 1.0e+00 AKTIP
Birth weight 2.25 1 0 0.0 0.00 1.0e+00 C1QTNF4
Forced vital capacity (FVC), Best measure 2.51 2 2 4.4 0.00 1.0e+00 ADCY3 C1QTNF4
Body fat percentage 16.66 11 9 20.0 0.94 1.8e-05 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R MTIF3 NEGR1
Leg fat percentage (right) 15.01 11 9 20.0 0.94 1.9e-05 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R NEGR1 RASA2
Arm fat-free mass (right) 9.88 11 10 22.2 0.94 1.4e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Comparative body size at age 10 45.14 12 11 24.4 0.92 1.8e-05 ADCY3 AKTIP C1QTNF4 EIF3CL FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Qualifications: College or University degree 4.18 3 2 4.4 0.00 1.0e+00 EIF3CL ETV5 NEGR1
Whole body fat mass 18.50 13 12 26.7 0.96 1.8e-07 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Leg fat mass (right) 19.55 14 11 24.4 0.96 7.2e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Arm predicted mass (right) 9.94 11 10 22.2 0.94 1.2e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Pulse rate, automated reading 1.63 2 1 2.2 0.00 1.0e+00 GPRC5B NEGR1
Alcohol intake frequency. 6.41 3 2 4.4 0.00 1.0e+00 C1QTNF4 EIF3CL NEGR1
Comparative height size at age 10 3.13 6 3 6.7 0.39 4.5e-01 ADCY3 C1QTNF4 EIF3CL FAIM2 FTO MTIF3
Suffer from 'nerves' 6.21 3 3 6.7 0.00 1.0e+00 C1QTNF4 EIF3CL MC4R
Commuting to job workplace: Car/motor vehicle 2.24 1 0 0.0 0.00 1.0e+00 NEGR1
Hypertension (Self-reported) 1.78 1 0 0.0 0.00 1.0e+00 NEGR1
Forced expiratory volume in 1-second (FEV1), predicted 2.50 2 0 0.0 0.00 1.0e+00 ADCY3 C1QTNF4
Whole body fat-free mass 10.31 11 10 22.2 0.94 1.5e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg fat-free mass (right) 12.69 11 11 24.4 0.96 4.3e-06 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Arm fat percentage (left) 21.64 13 11 24.4 0.94 2.3e-06 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B MAP2K5 MC4R MTIF3 NEGR1 RASA2
Handedness (chirality/laterality): Left-handed 2.91 1 0 0.0 0.00 1.0e+00 EIF3CL
Mood swings 1.56 1 0 0.0 0.00 1.0e+00 C1QTNF4
Loneliness, isolation 2.54 1 1 2.2 0.00 1.0e+00 C1QTNF4
Long-standing illness, disability or infirmity 2.70 1 0 0.0 0.00 1.0e+00 NEGR1
Diabetes diagnosed by doctor 2.88 1 0 0.0 0.00 1.0e+00 AKTIP
Qualifications: nursing, teaching 2.67 1 1 2.2 0.00 1.0e+00 NEGR1
Breast cancer (self-reported) 1.60 1 0 0.0 0.00 1.0e+00 FTO
Smoking status: Current 2.13 1 0 0.0 0.00 1.0e+00 C1QTNF4
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.12 1 0 0.0 0.00 1.0e+00 EIF3CL
Whole body water mass 10.33 11 10 22.2 0.94 1.5e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Leg predicted mass (right) 12.77 11 10 22.2 0.96 4.6e-06 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Arm fat mass (left) 21.76 14 12 26.7 0.96 5.6e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Number of self-reported non-cancer illnesses 2.34 1 1 2.2 0.00 1.0e+00 NEGR1
Miserableness 2.53 1 1 2.2 0.00 1.0e+00 C1QTNF4
Guilty feelings 2.98 1 0 0.0 0.00 1.0e+00 C1QTNF4
Hearing aid user 2.99 1 0 0.0 0.00 1.0e+00 ADCY3
Commuting to job workplace: Public transport 2.14 1 0 0.0 0.00 1.0e+00 NEGR1
Basal metabolic rate 11.86 12 10 22.2 0.95 3.3e-06 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Leg fat percentage (left) 15.77 11 9 20.0 0.95 8.5e-06 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO MAP2K5 MC4R NEGR1 RASA2
Arm fat-free mass (left) 10.72 11 10 22.2 0.94 1.4e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1
Number of operations (self-reported) 1.43 1 0 0.0 0.00 1.0e+00 NEGR1
Average weekly beer plus cider intake 4.27 1 0 0.0 0.00 1.0e+00 NEGR1
Diastolic blood pressure, automated reading 1.46 1 0 0.0 0.00 1.0e+00 MAP2K5
Vascular/heart problems diagnosed by doctor 1.71 2 0 0.0 0.00 1.0e+00 MAP2K5 NEGR1
Impedance of whole body 12.29 11 9 20.0 -0.95 8.6e-06 ADCY3 AKTIP ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R NEGR1 RASA2
Leg fat mass (left) 19.81 14 11 24.4 0.96 5.3e-08 ADCY3 AKTIP C1QTNF4 EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1 RASA2
Arm predicted mass (left) 10.43 11 10 22.2 0.94 1.3e-05 AKTIP EIF3CL ETV5 FAIM2 FTO GPRC5B KCTD15 MAP2K5 MC4R MTIF3 NEGR1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 11 0.325 1.5
GTEx Adipose Visceral Omentum 4 0.203 1.5
GTEx Adrenal Gland 2 0.141 1.3
GTEx Artery Aorta 10 0.348 1.5
GTEx Artery Coronary 2 0.173 1.5
GTEx Artery Tibial 10 0.275 1.5
GTEx Brain Caudate basal ganglia 2 0.224 1.5
GTEx Brain Cerebellar Hemisphere 1 0.069 1.6
GTEx Brain Cerebellum 1 0.052 1.6
GTEx Brain Cortex 4 0.399 1.6
GTEx Brain Frontal Cortex BA9 1 0.112 1.5
GTEx Brain Hippocampus 1 0.197 1.3
GTEx Brain Hypothalamus 1 0.175 1.5
GTEx Brain Nucleus accumbens basal ganglia 2 0.237 1.5
GTEx Brain Putamen basal ganglia 1 0.165 1.5
GTEx Breast Mammary Tissue 8 0.419 1.5
GTEx Breast Mammary Tissue (Male) 4 0.345 1.4
GTEx Breast Mammary Tissue (Female) 4 0.254 1.4
GTEx Cells EBV-transformed lymphocytes 1 0.073 1.5
GTEx Cells Transformed fibroblasts 8 0.196 1.5
GTEx Colon Sigmoid 4 0.281 1.4
GTEx Colon Transverse 6 0.302 1.5
GTEx Esophagus Gastroesophageal Junction 4 0.286 1.5
GTEx Esophagus Mucosa 5 0.155 1.5
GTEx Esophagus Muscularis 10 0.319 1.5
GTEx Heart Atrial Appendage 4 0.261 1.5
GTEx Heart Left Ventricle 6 0.406 1.6
GTEx Liver 3 0.430 1.6
GTEx Lung 6 0.216 1.5
GTEx Muscle Skeletal 6 0.214 1.5
GTEx Nerve Tibial 9 0.215 1.5
GTEx Ovary 5 0.567 1.6
GTEx Pancreas 3 0.189 1.5
GTEx Pituitary 2 0.183 1.5
GTEx Prostate 2 0.248 1.4
GTEx Skin Not Sun Exposed Suprapubic 8 0.334 1.5
GTEx Skin Sun Exposed Lower leg 9 0.255 1.5
GTEx Small Intestine Terminal Ileum 1 0.222 1.5
GTEx Spleen 5 0.363 1.6
GTEx Stomach 5 0.353 1.6
GTEx Testis 10 0.327 1.5
GTEx Thyroid 3 0.078 1.4
GTEx Uterus 1 0.181 1.4
GTEx Vagina 5 0.814 1.7
GTEx Whole Blood 7 0.365 1.6
METSIM Adipose 8 0.177 1.4
NTR Blood 2 0.084 1.3
ROSMAP Brain Pre-frontal Cortex 6 0.141 1.5
YFS Blood 3 0.066 1.3
CommonMind Brain Pre-frontal Cortex 8 0.152 1.3
The Cancer Genome Atlas Bladder Urothelial Carcinoma 4 0.259 1.4
The Cancer Genome Atlas Breast Invasive Carcinoma 6 0.145 1.3
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 2 0.192 1.5
The Cancer Genome Atlas Colon Adenocarcinoma 4 0.208 1.4
The Cancer Genome Atlas Esophageal Carcinoma 1 0.154 1.4
The Cancer Genome Atlas Glioblastoma Multiforme 1 0.104 1.4
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 6 0.234 1.4
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 6 0.155 1.3
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 5 0.259 1.4
The Cancer Genome Atlas Brain Lower Grade Glioma 5 0.123 1.4
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 4 0.384 1.4
The Cancer Genome Atlas Lung Adenocarcinoma 5 0.181 1.3
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 4 0.170 1.4
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 3 0.201 1.4
The Cancer Genome Atlas Pancreatic Adenocarcinoma 2 0.127 1.3
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 2 0.160 1.3
The Cancer Genome Atlas Prostate Adenocarcinoma 4 0.092 1.3
The Cancer Genome Atlas Rectum Adenocarcinoma 0 0.000 1.2
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.101 1.3
The Cancer Genome Atlas Skin Cutaneous Melanoma 2 0.405 1.3
The Cancer Genome Atlas Stomach Adenocarcinoma 3 0.189 1.4
The Cancer Genome Atlas Testicular Germ Cell Tumors 0 0.000 1.3
The Cancer Genome Atlas Thyroid Carcinoma 5 0.102 1.3
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 1 0.208 1.3